Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Heat-triggered phospholipid flipping stabilizes plasma membrane fluidity.

Nature·2026

Same author

Radiographic Evaluation of Peri-Implant Bone Thickness in Fibular Mandible Reconstruction With Preoperative Occlusion-Driven Design.

The Journal of craniofacial surgery·2026

Same author

Global Snow-free Leaf Area Index Dataset 1985-2020 for Earth System Modeling.

Scientific data·2026

Same author

Orbital hybridization-mediated nanozymes reverse cellular senescence for aged bone regeneration.

Biomaterials·2026

Same author

Achieving Superior Mechanical Properties in CoCrNiCuFe High-Entropy Alloys via Synergistic Design of Composition and Gradient Nanostructure.

Langmuir : the ACS journal of surfaces and colloids·2026

Same author

The impact of clinical internship experiences on professional identity among nursing undergraduates: A qualitative study based on control-value theory.

Nurse education today·2026

Search research articles

Related Experiment Video

Updated: Aug 17, 2025

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Primary vaginal sarcoma in a single center.

Hua Yuan¹, Tonghui Wang²

¹Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Gynecologic Oncology Reports

|December 12, 2022

Summary

Primary vaginal sarcomas are aggressive and often recur. Surgery is the primary treatment for these rare tumors and for local recurrences, offering a chance for better survival outcomes.

Keywords:

Clinical characteristics Prognosis Vaginal sarcoma

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Related Experiment Videos

Last Updated: Aug 17, 2025

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Area of Science:

Gynecologic Oncology
Surgical Pathology
Rare Cancers

Background:

Primary vaginal sarcoma is a rare and aggressive malignancy.
Understanding its clinical characteristics and prognosis is crucial for effective management.

Purpose of the Study:

To investigate the clinical characteristics and prognosis of primary vaginal sarcoma.
To evaluate treatment outcomes and survival rates.

Main Methods:

Retrospective analysis of 15 primary vaginal sarcoma patients treated between 2000 and 2020.
Review of clinical data, treatment modalities, and follow-up information.

Main Results:

Leiomyosarcoma was the most common type (60.0%).
Vaginal mass was the most frequent presenting symptom.
High rates of disease extent (86.7%) and local relapse (84.6%) were observed.
Two-year and five-year overall survival rates were 80.0% and 66.7%, respectively.
Surgery is the main treatment for primary and recurrent disease.

Conclusions:

Primary vaginal sarcomas are aggressive neoplasms with diverse clinical presentations.
Surgery is the cornerstone of treatment for both initial diagnosis and local recurrence.
Timely surgical intervention may improve prognosis for patients with vaginal sarcoma.